Skip to content
★ Sign in to follow
KH

Kenneth H. Paulus

Executive
Teladoc Health, Inc.Cogentix Medical Inc /DE/Team Health Holdings Inc.Uroplasty Inc
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
10
Companies
4
▲ Purchases (2 ops.)
€118k
▼ Sales (1 ops.)
€1.4M

Latest filing published 17 Nov 2025 for Teladoc Health, Inc., €60k.

Filing timeline

BuySale
Kenneth H. Paulus

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 17 Nov 2025 · 356 days ago · €60k
    -9.7%
    Entry US$7.00 · Close 22 Oct 2026 US$6.32

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Kenneth H. Paulus: trading record in brief

This profile gathers the share dealings of Kenneth H. Paulus across 4 companies, led by Team Health Holdings Inc., Teladoc Health, Inc. and Cogentix Medical Inc /DE/. Between 30 October 2014 and 14 November 2025, the trades on record add up to 10 filings.

Market trades split into 2 purchases (€118k) and 1 sale (€1.4M). Netting one side against the other leaves €1.3M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 1 option exercise. So far in 2025, the count stands at 1 purchase and no sales.

The latest filing, published on 17 November 2025, reports an open-market purchase of €60k in Teladoc Health, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kenneth H. Paulus

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations